Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
Location status: Recruiting
Recruiting
NCT Number: NCT07805083
Community Enhanced Virtual Informed Consent
The goal of this clinical trial is to examine perceptions of virtual human communicators and cancer research recruitment messages. This study will also examine how different informed consent approaches influence decisions to participate in research.
Recruiting
Interested in participating?
Request InfoKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Able to speak, read, or understand English sufficiently to provide informed consent
- 18 years of age or older
- White or Black
- Living in the United States
Exclusion criteria
- Unable to speak, read, or understand English sufficiently to provide informed consent
- Inability on the part of the patient to understand the informed consent or be compliant with the protocol
Treatment and study plan
Educational Cancer Intervention
BehavioralParticipants will view informed consent messaging presented in different formats
Other names: Behavioural
ICF Text Version 1
OtherReceive a text-based informed consent form
Other names: Formal Consent, Informed Consent, INFORMED CONSENT OBTAINED
ICF Text Version 2
OtherReceive an adapted text-based informed consent form
Other names: Formal Consent, Informed Consent, INFORMED CONSENT OBTAINED
ICF Video Version 1
OtherReceive a video-based informed consent form delivered by virtual human #1
Other names: Formal Consent, Informed Consent, INFORMED CONSENT OBTAINED
ICF Video Version 2
OtherReceive a video-based informed consent form delivered by virtual human #2
Other names: Formal Consent, Informed Consent, INFORMED CONSENT OBTAINED
ICF Video Version 3
OtherReceive a video-based informed consent form delivered by virtual human #3
Other names: Formal Consent, Informed Consent, INFORMED CONSENT OBTAINED
ICF Video Version 4
OtherReceive a video-based informed consent form delivered by virtual human #4
Other names: Formal Consent, Informed Consent, INFORMED CONSENT OBTAINED
Survey Administration
OtherAncillary studies
Primary outcomes
-
Self-efficacy (Aim 1)
Time frame: Baseline (immediately following intervention)
Assessed by 3 questions in the study-specific survey. The questions are answered on a scale of 1 (strongly disagree) to 5=strongly agree. Higher scores indicate greater feelings of self-efficacy.
-
Trustworthiness (Aim 2)
Time frame: Baseline (immediately following intervention)
Assessed by a study-specific survey asking participants to rate the intervention on a scale of 1 (untrustworthy) to 7 (trustworthy). Higher scores indicate greater perception of trustworthiness.
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Mayo Clinic
Other
Registry information
Official study title
Exploring Health Communication Message Factors That Influence Cancer Research Recruitment
Acronym: CEVIC
Important dates
- Study start
- 2026
- Primary completion
- 2027
- Study completion
- 2029
- First posted
- Sep 4, 2026
- Registry last updated
- Sep 8, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Recruiting
Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer
NCT06562777
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Portland, Oregon, United States
View Trial Details
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
NCT06513962
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Birmingham, Alabama, United States
View Trial Details
Recruiting
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting
NCT07126301
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Duarte, California, United States
View Trial Details
Recruiting
CREATE: Art for Children With Cancer
NCT06342453
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Portland, Oregon, United States
View Trial Details